FDA Approved: METOCLOPRAMIDE — Supplemental Application (Ipca Laboratories Limited)

View source ↗

Summary

The FDA approved a supplemental application for metoclopramide from Ipca Laboratories Limited, indicating an approved change to the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Gastroparesis
• Nausea and Vomiting

Drugs mentioned

• Metoclopramide (metoclopramide)

Snippet

SUPPL AP for METOCLOPRAMIDE (METOCLOPRAMIDE)